MMV006087 is a potent Malaria Box compound against Plasmodium falciparum clinical parasites
The emergence of drug-resistant malaria parasites to artemisinin and its partner drugs highlights the need to increase the arsenal of new antimalarials with novel mechanisms of action. To help achieve this aim, this study tested the potency of three Malaria Box compounds (MMV006087, MMV085203, and M...
Main Authors: | Jersley D. Chirawurah, Bridget Adikah, Felix Ansah, Elizabeth Laryea-Akrong, Harry Danwonno, Collins M. Morang’a, Daniel Dosoo, Lucas Amenga-Etego, Gordon A. Awandare, Yaw Aniweh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Drug Discovery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fddsv.2023.1190471/full |
Similar Items
-
Gossypol is a natural product with good antimalarial activity against Plasmodium falciparum clinical isolates
by: Jersley D. Chirawurah, et al.
Published: (2025-01-01) -
Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana
by: Yaw Aniweh, et al.
Published: (2023-06-01) -
Machine learning approaches classify clinical malaria outcomes based on haematological parameters
by: Collins M. Morang’a, et al.
Published: (2020-11-01) -
Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates
by: Jersley D. Chirawurah, et al.
Published: (2017-12-01) -
Co-infection of Plasmodium falciparum and Schistosoma mansoni is associated with anaemia
by: Sylvester Donne Dassah, et al.
Published: (2023-09-01)